Clorox (NYSE:CLX – Free Report) had its target price trimmed by DA Davidson from $171.00 to $169.00 in a report published on Wednesday morning,Benzinga reports. The brokerage currently has a neutral rating on the stock. DA Davidson also issued estimates for Clorox’s FY2025 earnings at $6.65 EPS and FY2026 earnings at $6.32 EPS.
A number of other research firms have also recently commented on CLX. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and increased their target price for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. JPMorgan Chase & Co. increased their target price on shares of Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research report on Tuesday. Evercore ISI increased their target price on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday. Wells Fargo & Company raised their price objective on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Finally, Barclays reduced their price target on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a research report on Friday, January 17th. Four analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $158.21.
View Our Latest Stock Report on CLX
Clorox Price Performance
Clorox (NYSE:CLX – Get Free Report) last released its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 4.78% and a return on equity of 316.08%. During the same period in the prior year, the firm earned $2.16 EPS. Equities analysts expect that Clorox will post 6.86 earnings per share for the current year.
Clorox Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.29%. Clorox’s dividend payout ratio is currently 170.04%.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of CLX. Brooklyn Investment Group lifted its holdings in Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after acquiring an additional 95 shares during the period. Prospera Private Wealth LLC bought a new position in shares of Clorox in the third quarter worth about $27,000. Continuum Advisory LLC raised its stake in shares of Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after buying an additional 138 shares during the period. Asset Planning Inc bought a new position in shares of Clorox in the fourth quarter worth about $32,000. Finally, Halbert Hargrove Global Advisors LLC bought a new position in shares of Clorox in the fourth quarter worth about $36,000. 78.53% of the stock is owned by institutional investors.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- What Are Earnings Reports?
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- 3 Ways To Invest In Coffee, Other Than Drinking It
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.